These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32694282)

  • 1. Inter- and intraobserver agreement in standard and ultra-fast single-photon emission computed tomography/computed tomography for the assessment of bone metastases.
    Zacho HD; Aleksyniene R; Ejlersen JA; Fledelius J; Petersen LJ
    Nucl Med Commun; 2020 Oct; 41(10):1005-1009. PubMed ID: 32694282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT.
    Zacho HD; Manresa JAB; Aleksyniene R; Ejlersen JA; Fledelius J; Bertelsen H; Petersen LJ
    EJNMMI Res; 2017 Dec; 7(1):1. PubMed ID: 28058659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-observer variability between readers in detection of bone metastases comparing different modalities; PET/CT, SPECT/CT and planar bone scintigraphy.
    Bashank N; Hussein A; Mekawy M; Askar H
    Nucl Med Commun; 2023 Jul; 44(7):604-612. PubMed ID: 37114413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
    Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O
    Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body bone SPECT in breast cancer patients: the future bone scan protocol?
    Abikhzer G; Gourevich K; Kagna O; Israel O; Frenkel A; Keidar Z
    Nucl Med Commun; 2016 Mar; 37(3):247-53. PubMed ID: 26528786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.
    Arvola S; Seppänen M; Malaspina S; Mätzke S; Raiko J; Timonen KL; Ettala O; Jambor I; Anttinen M; Kuisma A; Löyttyniemi E; Boström PJ; Sohlberg A; Noponen T
    Nucl Med Commun; 2022 May; 43(5):510-517. PubMed ID: 35081092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients.
    Guezennec C; Keromnes N; Robin P; Abgral R; Bourhis D; Querellou S; de Laroche R; Le Duc-Pennec A; Salaün PY; Le Roux PY
    Cancer Imaging; 2017 Jun; 17(1):16. PubMed ID: 28592305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-MIP-1404 SPECT/CT for Patients With Metastatic Prostate Cancer: Interobserver and Intraobserver Variability in Treatment-Related Longitudinal Tracer Uptake Assessments of Prostate-Specific Membrane Antigen-Positive Lesions.
    Schmidkonz C; Atzinger A; Goetz TI; Beck M; Ritt P; Prante O; Kuwert T; Bäuerle T; Cordes M
    Clin Nucl Med; 2020 Feb; 45(2):105-112. PubMed ID: 31876822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate.
    Helyar V; Mohan HK; Barwick T; Livieratos L; Gnanasegaran G; Clarke SE; Fogelman I
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):706-13. PubMed ID: 20016889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
    de Leiris N; Leenhardt J; Boussat B; Montemagno C; Seiller A; Phan Sy O; Roux J; Laramas M; Verry C; Iriart C; Fiard G; Long JA; Descotes JL; Vuillez JP; Riou L; Djaileb L
    Cancer Imaging; 2020 Aug; 20(1):58. PubMed ID: 32787923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D SPECT/CT fusion using image data projection of bone SPECT onto 3D volume-rendered CT images: feasibility and clinical impact in the diagnosis of bone metastasis.
    Ogata Y; Nakahara T; Ode K; Matsusaka Y; Katagiri M; Iwabuchi Y; Itoh K; Ichimura A; Jinzaki M
    Ann Nucl Med; 2017 May; 31(4):304-314. PubMed ID: 28243844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diagnostic Characteristic and Reproducibility of Bone Scintigraphy Single-Photon Emission Computed Tomography/Computed Tomography for Diagnosing Aseptic Loosening of Uncemented Total Knee Arthroplasty.
    Puijk R; Lubbe P; Sierevelt IN; Kristians AE; Boer J; Nolte PA
    J Arthroplasty; 2024 Jul; 39(7):1707-1713.e1. PubMed ID: 38218556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indeterminate lesions on planar bone scintigraphy in lung cancer patients: SPECT, CT or SPECT-CT?
    Sharma P; Kumar R; Singh H; Bal C; Julka PK; Thulkar S; Malhotra A
    Skeletal Radiol; 2012 Jul; 41(7):843-50. PubMed ID: 22002100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of SPECT-CT on bone scintigraphy in oncology: Pattern approach.
    Tuncel M; Lay Ergun E; Caglar Tuncali M
    J BUON; 2016; 21(5):1296-1306. PubMed ID: 27837636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial.
    Jambor I; Kuisma A; Ramadan S; Huovinen R; Sandell M; Kajander S; Kemppainen J; Kauppila E; Auren J; Merisaari H; Saunavaara J; Noponen T; Minn H; Aronen HJ; Seppänen M
    Acta Oncol; 2016; 55(1):59-67. PubMed ID: 25833330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases.
    Stecco A; Lombardi M; Leva L; Brambilla M; Negru E; Delli Passeri S; Carriero A
    Radiol Med; 2013 Apr; 118(3):465-75. PubMed ID: 22872462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.
    Zhang Y; Li B; Yu H; Song J; Zhou Y; Shi H
    Nucl Med Commun; 2021 Jan; 42(1):63-67. PubMed ID: 33044406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.